Sateesh Reddy Nallapalle

Learn More
We investigated risk association of FAS (−1377 G>A and −670 A>G) and FASL (−844 T>C) promoter polymorphisms with breast, ovarian, cervical, and endometrial cancers and report that the FASL −844 CC genotype was protective against breast, ovarian, cervical, and endometrial cancers (P ≤ 0.01). On the other hand, FAS −1377 GA and AA variants increased risk of(More)
We investigated risk association of oral cancers (tongue and buccal mucosa cancers) with FAS (−1377G > A and FAS −670 A > G) and FASL (−844 T > C) SNPs, in males and females. A case–control study of 535 oral cancer and 525 control subjects was performed. SNPs were detected in the genomic DNA isolated from peripheral blood using PCR-RFLP. We report FASL −844(More)
  • 1